Hochschulschrift
Die Antileukoproteinase "secretory leukocyte protease inhibitor" (SLPI) und ihre potentielle Bedeutung für die Prävention von HPV-Infektionen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
55 Seiten
- Language
-
Deutsch
- Notes
-
Diagramme
Christian-Albrechts-Universität zu Kiel, Dissertation, 2018
- Keyword
-
Infektion
Rauchen
Proteasen
Leukozytenzählung
Humanes Papillomavirus
- Event
-
Veröffentlichung
- (where)
-
Kiel
- (when)
-
[2018]
- Creator
- Contributor
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:37 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Time of origin
- [2018]
Other Objects (12)
Endogenous secretory leukocyte protease inhibitor inhibits microbial‐induced monocyte activation
Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways
Secretory Leukocyte Protease Inhibitor in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma
Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines
Humane Papillomvirus-Infektionen in Karzinomen des Kopf- und Halsbereiches : die Rolle der Antileukoproteinase „secretory leukocyte protease inhibitor“ (SLPI) in Tabakrauch-induzierten, HPV-unabhängigen Plattenepithelkarzinomen
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen : die Rolle der Antileukoproteinase "Secretory Leukocyte Protease Inhibitor" (SLPI)
Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen: die Rolle der Antileukoproteinase „Secretory Leukocyte Protease Inhibitor“ (SLPI)
Regulation der "Secretory Leukocyte Protease Inhibitor"-Expression in Magenepithelzellen unter dem Einfluss der Infektion mit Helicobacter pylori
Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
Salivary secretory leukocyte protease inhibitor levels in patients with stage 3 grade C periodontitis: a comparative cross-sectional study
Endogenous secretory leukocyte protease inhibitor inhibits microbial‐induced monocyte activation
Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways
Secretory Leukocyte Protease Inhibitor in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma
Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines
Humane Papillomvirus-Infektionen in Karzinomen des Kopf- und Halsbereiches : die Rolle der Antileukoproteinase „secretory leukocyte protease inhibitor“ (SLPI) in Tabakrauch-induzierten, HPV-unabhängigen Plattenepithelkarzinomen
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen : die Rolle der Antileukoproteinase "Secretory Leukocyte Protease Inhibitor" (SLPI)
Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen: die Rolle der Antileukoproteinase „Secretory Leukocyte Protease Inhibitor“ (SLPI)
Regulation der "Secretory Leukocyte Protease Inhibitor"-Expression in Magenepithelzellen unter dem Einfluss der Infektion mit Helicobacter pylori
Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression
Salivary secretory leukocyte protease inhibitor levels in patients with stage 3 grade C periodontitis: a comparative cross-sectional study
Endogenous secretory leukocyte protease inhibitor inhibits microbial‐induced monocyte activation
Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways
Secretory Leukocyte Protease Inhibitor in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma
Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines
Humane Papillomvirus-Infektionen in Karzinomen des Kopf- und Halsbereiches : die Rolle der Antileukoproteinase „secretory leukocyte protease inhibitor“ (SLPI) in Tabakrauch-induzierten, HPV-unabhängigen Plattenepithelkarzinomen
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen : die Rolle der Antileukoproteinase "Secretory Leukocyte Protease Inhibitor" (SLPI)
Recombinant human secretory leukocyte protease inhibitor (rhSLPI) coated titanium enhanced human osteoblast adhesion and differentiation
Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1
Humane Papillomvirus-Infektion in Kopf- und Halskarzinomen: die Rolle der Antileukoproteinase „Secretory Leukocyte Protease Inhibitor“ (SLPI)
Regulation der "Secretory Leukocyte Protease Inhibitor"-Expression in Magenepithelzellen unter dem Einfluss der Infektion mit Helicobacter pylori
Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression